← 返回首页
美国 · 平台与数据 · MarketBeat

Ionis Pharmaceuticals Sticks to $3 Billion TRYNGOLZA Sales Goal Despite Slow Start

来源:MarketBeat · 美国 49 分钟前
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

详细摘要

Ionis Pharmaceuticals (NASDAQ:IONS) remains confident that its triglyceride-lowering drug TRYNGOLZA can generate more than $3 billion in peak annual U.S. sales, even as its launch has started more slowly than expected, CEO Brett Monia said at the UBS Global Biopharma Conference. Monia said physicia

在 MarketBeat 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)

推荐阅读